TARA BAIRD: Open Payments
NPI 1124495049 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 42 payments from 11 companies in 2025. Trend: 2023 $1,223 · 2024 $1,107 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $478 |
| Alkermes, Inc. | 6 | $241 |
| Otsuka America Pharmaceutical, Inc. | 13 | $145 |
| E.R. Squibb & Sons, L.L.C. | 1 | $96 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Lundbeck LLC | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $20 |
Products named: CAPLYTA, ARISTADA, REXULTI, COBENFY, LYBALVI, INGREZZA, ABILIFY MAINTENA, Auvelity.
Industry payments across KS — which companies pay providers there.
